| Literature DB >> 26664554 |
Amine Slaoui1, Youness Jabbour1, Anouar El Ghazoui1, Tarik Karmouni1, Khalid Elkhader1, Abdelatif Koutani1, Ahmed Ibn Attaya1.
Abstract
UNLABELLED: The aim of our study was to report the status of penile cancer sites in the urology department at the University Hospital of Rabat and evaluate long-term results of surgical treatment of this cancer. PATIENTS AND METHODS: Between 1989 and 2015, 10 patients were treated for penile cancer. 10 cases were retrospectively reviewed and the following data were recorded: mode of revelation, seat, staging, TNM stage, treatment, evolution and survival. The mean age of patients was 58,1 years (48-81 years). All patients had squamous cell carcinoma of the penis. Six patients had a partial amputation of the penis, and three patients underwent total amputation. The median size of the lesion was 4.25 cm (1.5-8 cm). All tumors had a distal seat (gland- Furrow balanopreputial), 8 were localized and non-invasive (PT1 - PT2) and 2 had infiltrated the urethra (PT3). Four patients had lymph node localization. A single bilateral lymphadenectomy was performed and was positive only on one side, with a node <3 cm and no extracapsular extension. Two patients were referred for chemotherapy, a neoadjuvant referred to basic (Bleomycin - Methotrexate, Cisplatin) the other in a palliative goal. Median follow-up was 42 months (6 -72mois). Four patients died, one of which was presented immediately with metastatic mode. Six patients were alive at last node or local recurrence negative. Cancer of the penis seems rare in Morocco. His oncologic and functional outcomes (sexual and urinary) depend on the precocity of the treatment. The surgery of lymph node resection with lymphadenectomy remains the reference treatment.Entities:
Keywords: Partial penectomy; Penile Cancer; lymphadenectomy; total penectomy
Mesh:
Substances:
Year: 2015 PMID: 26664554 PMCID: PMC4662521 DOI: 10.11604/pamj.2015.22.53.6563
Source DB: PubMed Journal: Pan Afr Med J
Main characteristics of patients
| P1 | P2 | P3 | P4 | P5 | P6 | P7 | P8 | P9 | P10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Age Diagnosis | 55 years | 81 years | 58 years | 48 years | 49 years | 72 years | 46 years | 59 years | 55 years | 58 years |
| location | glans | Balanopreputial groove | balanopreputial groove | glans | glans | body | glans | glans | glans | glans |
| size | 1,5 cm | 5 cm | 3 cm | 4 cm | 5 cm | 8 cm | 3 cm | 3 cm | 4 cm | 6 cm |
| PT | PT1 | PT2 | pT2 | PT1 | PT1 | PT3 | PT1 | PT1 | PT1 | PT3 |
| N | N0 | N2 | N1 | N0 | N0 | N3 | N0 | N0 | N1 | N0 |
| M | M0 | M0 | M0 | M0 | M0 | M + | M0 | M0 | M0 | M0 |
| G | 1 | 2 | 1 | 1 | 1 | - | 1 | 1 | 1 | 2 |
| Emboli V/L | V0 | - | V0/LO | - | - | - | - | - | - | - |
| Preoperativeassessment | CT | CT | MRI | CT | CT | CT | CT | CT | CT | CT |
| Precancerous lesion or HPV infection | + | - | - | - | - | - | - | - | - | + |
| Resectionmargin | - | - | - | - | - | - | - | - | - | - |
| treatment | Partial penectomy | Total penecto my + neoadjuvant chemo | Total penectomy | Partial penectomy | Partial penectomy | Palliative chemo | Partial penectomy | Partial penectomy | Partial penectomy | Total penectomy |
| follow | 5 years | 1 year | 3 years | 5 years | 6 years | 6 mounths | 4 years | 5 years | 2 years | - |
| recidivism | no | no | No | no | no | no | no | no | no | - |
| death | yes | yes | Yes | no | no | yes | no | no | no | no |
Figure 1Cauliflower appearance of the tumor
Figure 2Infiltration of the urethra (HEx100)
Figure 3Appearance after total penectomy
Figure 4Resected specimen
Figure 5Perineal urethrostomy
Figure 6Dyskeratotic cells with tumor proliferation (HEx400)
Figure 7Cutaneous coatings adjacent to the tumor showing parakeratosis. Koilocytespresence (HEx200)